Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
Lung Cancer

New Lung Cancer Treatment Approved By NHS Scotland

Posted on October 14, 2019
Post Views: 778

The Scottish Medicines Consortium (SMC) confirms another immunotherapy treatment in combination with chemotherapy drugs is to be made available on NHS for patients with advanced lung cancer. The decision has been to accept MSD’s immunotherapy Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy on NHS in Scotland for first-line treatment of metastatic non-small cell lung cancer (NSCLC) patients.

A new lung cancer treatment that can help patients, have been approved for use by NHS in Scotland. The doctors and campaigners welcomed the decision by SMC to allow the drug Keytruda, also known as pembrolizumab, to be used along with chemotherapy. This allows one to treat people with advanced stage of non-small cell lung cancer.

In the study, a total of 5331 Scots were diagnosed with disease in 2017 and only 9.8% are still alive five year after diagnosis. This new decision which involves patients with NSCLC can benefit from immunotherapy treatment as well as chemotherapy. NSCLC accounts for about 90% of total lung cancer patients.

Dr. Brian Clark of the Beatson West of Scotland Cancer Centre in Glasgow said, “While single-agent immunotherapy has been helping Scottish patients for several years, it is clear many patients benefit from the combination of chemotherapy and immunotherapy. This is an important development in the treatment of lung cancer in Scotland, where it remains the leading cause of cancer death in men and women.” SMC has also approved Yescarta, for treating blood cancer lymphoma.

This new decision has been very welcome news for lung cancer patients in Scotland. Scotland has had one of the highest rates of lung cancer in the world. About nine out of ten patients with lung cancer have NSCLC. While single-agent immunotherapy has been helping Scotland patients for years and now, this combination of chemotherapy and immunotherapy is going to benefit patients.

The information shared in this blog is for educational purposes only.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,324)
  • Lung Cancer: Symptoms and Treatment (5,655)
  • What is Non-Small-Cell Lung Cancer? (5,551)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • Study: Wildfire Smoke Exposure Affects Lung Cancer Survival June 2, 2025
  • Predicting Lung Cancer Risk with AI based Deep Learning Model May 26, 2025
  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha.
  • Privacy Policy
  • About Us
  • Sitemap
  • Contact Us
%d